18-68836786-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024781.3(CCDC102B):c.23G>A(p.Arg8Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,612,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024781.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC102B | NM_024781.3 | c.23G>A | p.Arg8Gln | missense_variant | 2/8 | ENST00000360242.9 | NP_079057.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC102B | ENST00000360242.9 | c.23G>A | p.Arg8Gln | missense_variant | 2/8 | 1 | NM_024781.3 | ENSP00000353377.5 |
Frequencies
GnomAD3 genomes AF: 0.000185 AC: 28AN: 151258Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000165 AC: 41AN: 248694Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 134976
GnomAD4 exome AF: 0.000250 AC: 365AN: 1461058Hom.: 0 Cov.: 32 AF XY: 0.000249 AC XY: 181AN XY: 726870
GnomAD4 genome AF: 0.000185 AC: 28AN: 151364Hom.: 0 Cov.: 31 AF XY: 0.000162 AC XY: 12AN XY: 73852
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.23G>A (p.R8Q) alteration is located in exon 4 (coding exon 1) of the CCDC102B gene. This alteration results from a G to A substitution at nucleotide position 23, causing the arginine (R) at amino acid position 8 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at